Biomerica Inc Share Price Today: Live Updates & Key Insights

Biomerica Inc share price today is $2.2, up 5.29%. The stock opened at $2.15 against the previous close of $2.08, with an intraday high of $2.22 and low of $2.09.

Biomerica Inc Share Price Chart

Biomerica Inc

us-stock
To Invest in {{usstockname}}
us-stock

Biomerica Inc Share Price Performance

$2.2 0.0529(5.29%) BMRA at 23 Mar 2026 12:16 PM Medical Devices
Lowest Today 2.09
Highest Today 2.22
Today’s Open 2.15
Prev. Close 2.08
52 Week High 5.92
52 Week Low 1.87
Day’s Range: Low 2.09 High 2.22
52-Week Range: Low 1.87 High 5.92
1 day return -
1 Week return +4.76
1 month return +5.76
3 month return -6.77
6 month return -23.34
1 year return +211.48
3 year return +17.64
5 year return -66.2
10 year return -

Biomerica Inc Institutional Holdings

Vanguard Group Inc 0.70

BlackRock Inc 0.62

Geode Capital Management, LLC 0.62

Vanguard Institutional Extnd Mkt Idx Tr 0.48

Fidelity Extended Market Index 0.39

DRW Securities, LLC 0.34

Goss Wealth Management LLC 0.12

Fidelity Series Total Market Index 0.12

Fidelity Total Market Index 0.06

Spartan Total Market Index Pool G 0.05

Hollencrest Securities, LLC 0.05

Northern Trust Extended Eq Market Idx 0.04

NT Ext Equity Mkt Idx Fd - L 0.04

NT Ext Equity Mkt Idx Fd - NL 0.03

Citigroup Inc 0.03

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.03

Atlantic Trust Group, LLC 0.02

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.02

Morgan Stanley - Brokerage Accounts 0.01

State St US Ttl Mkt Indx NL Cl A 0.01

Northern Trust Wilshire 5000 0.00

NT US Market Cap Idx Fd - L 0.00

BNYM Mellon SL Market Completion UC1 0.00

HARBOUR INVESTMENTS, INC. 0.00

UBS Group AG 0.00

NT Quality SCC US Fund - L 0.00

NT Quality Small Cap Core 0.00

Bank of America Corp 0.00

Spartan Extended Market Index Pool F 0.00

Fidelity U.S. Equity Index Ins Trust 0.00

SBI Securities Co Ltd 0.00

Danske Bank A/S. 0.00

Tower Research Capital LLC 0.00

TWO SIGMA SECURITIES, LLC 0.00

Biomerica Inc Market Status

Biomerica Inc Fundamentals

Market Cap 7.37 M

PB Ratio 1.4913

PE Ratio 0.0

Enterprise Value 4.35 M

Total Assets 5.95 M

Volume 54012

Biomerica Inc Company Financials

Annual Revenue FY25:5311000 5.3M, FY24:5415000 5.4M, FY23:5339000 5.3M, FY22:18871409 18.9M, FY21:7199027 7.2M

Annual Profit FY25:498000 0.5M, FY24:611000 0.6M, FY23:446000 0.4M, FY22:2977418 3.0M, FY21:496981 0.5M

Annual Net worth FY25:-4973000 -5.0M, FY24:-5978000 -6.0M, FY23:-7140000 -7.1M, FY22:-4531044 -4.5M, FY21:-6469036 -6.5M

Quarterly Revenue Q4/2025:1210000 1.2M, Q3/2025:1380000 1.4M, Q2/2025:749000 0.7M, Q1/2025:1119000 1.1M, Q4/2024:1636000 1.6M

Quarterly Profit Q4/2025:51000 0.1M, Q3/2025:424000 0.4M, Q2/2025:-244000 -0.2M, Q1/2025:19000 0.0M, Q4/2024:437000 0.4M

Quarterly Net worth Q4/2025:-1320000 -1.3M, Q3/2025:2000 0.0M, Q2/2025:-1544000 -1.5M, Q1/2025:-1163000 -1.2M, Q4/2024:-950000 -1.0M

About Biomerica Inc & investment objective

Company Information Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the Helicobacter pylori bacteria. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.

Organisation Medical Devices

Employees 53

Industry Medical Devices

CEO Mr. Zackary S. Irani

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Biomerica Inc FAQs

What is the share price of Biomerica Inc today?

The current share price of Biomerica Inc is $2.2.

Can I buy Biomerica Inc shares in India?

Yes, Indian investors can buy Biomerica Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Biomerica Inc shares in India?

You can easily invest in Biomerica Inc shares from India by:

Can I buy fractional shares of Biomerica Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Biomerica Inc?

Biomerica Inc has a market cap of $7.37 M.

In which sector does Biomerica Inc belong?

Biomerica Inc operates in the Medical Devices sector.

What documents are required to invest in Biomerica Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Biomerica Inc?

The PE ratio of Biomerica Inc is N/A and the PB ratio is 1.49.